Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
about
Pneumococcal whole-cell and protein-based vaccines: changing the paradigm.A Detrimental Influence of Alveolar Macrophages on Protective Humoral Immunity during Francisella tularensis SchuS4 Pulmonary Infection.Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.An Improved Tobacco Mosaic Virus (TMV)-Conjugated Multiantigen Subunit Vaccine Against Respiratory Tularemia.
P2860
Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Monophosphoryl Lipid A Enhance ...... Humoral and Cellular Immunity.
@ast
Monophosphoryl Lipid A Enhance ...... Humoral and Cellular Immunity.
@en
type
label
Monophosphoryl Lipid A Enhance ...... Humoral and Cellular Immunity.
@ast
Monophosphoryl Lipid A Enhance ...... Humoral and Cellular Immunity.
@en
prefLabel
Monophosphoryl Lipid A Enhance ...... Humoral and Cellular Immunity.
@ast
Monophosphoryl Lipid A Enhance ...... Humoral and Cellular Immunity.
@en
P2093
P2860
P356
P1476
Monophosphoryl Lipid A Enhance ...... Humoral and Cellular Immunity.
@en
P2093
Aiping Qin
Barbara J Mann
Eileen M Barry
Katharina Richard
Stefanie N Vogel
P2860
P356
10.1128/CVI.00574-16
P577
2017-01-11T00:00:00Z